Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion

Journal of the American College of Cardiology

Volumn 19, Issue 6, 1992, Pages 1123-1128

  Topol, Eric J ^a   Armstrong, Paul ^a   Van de Werf, Frans ^a   Kleiman, Neal ^a   Lee, Kerry ^a   Morris, Douglas ^a   Simoons, Maarten ^a   Barbash, Gabriel ^a   White, Harvey ^a   Califf, Robert M ^a   Global Utilization of Streptokinase, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; STREPTOKINASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY REPERFUSION; DRUG SAFETY; HEART MUSCLE REPERFUSION; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; BIOMEDICAL RESEARCH; CLINICAL APPROACH/SOURCE; INTERNATIONAL ASPECTS; REMUNERATION; RESEARCH SUBJECTS; RISKS AND BENEFITS; SELECTION OF SUBJECTS; THERAPEUTIC RESEARCH;

CONFLICT OF INTEREST; CORONARY DISEASE; DRUG INDUSTRY; DRUG THERAPY, COMBINATION; HEPARIN; HUMAN; INTERNATIONAL COOPERATION; INTERPROFESSIONAL RELATIONS; MYOCARDIAL REPERFUSION; OBSERVER VARIATION; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS; RECOMBINANT PROTEINS; RESEARCH DESIGN; SAFETY; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 0026521772     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)